TSX:BLU - CA0959221007 - Common Stock
The current stock price of BLU.CA is 0.65 CAD. In the past month the price increased by 44.44%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
EDT.CA | SPECTRAL MEDICAL INC | N/A | 485.89M | ||
FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 339.25M | ||
EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 263.59M | ||
TH.CA | THERATECHNOLOGIES INC | N/A | 209.21M | ||
HBP.CA | HELIX BIOPHARMA CORP | N/A | 113.04M | ||
WLLW.CA | WILLOW BIOSCIENCES INC | N/A | 97.56M | ||
MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 88.41M | ||
MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 68.23M | ||
NRX.CA | NUREXONE BIOLOGIC INC | N/A | 67.21M | ||
COV.CA | COVALON TECHNOLOGIES LTD | 17.54 | 62.52M | ||
SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 49.83M | ||
MBX.CA | MICROBIX BIOSYSTEMS INC | N/A | 32.91M |
BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. The company is headquartered in Laval, Quebec and currently employs 74 full-time employees. The company went IPO on 2000-06-22. The firm's lead product candidate, BLU-5937, which is a selective, small molecule antagonist of the P2X3 receptor, as an oral therapy to reduce cough frequency in RCC patients. The firm has completed the BLUEPRINT clinical trial, a Phase II trial evaluating BLU-5937 in patients with chronic pruritus associated with AD. The firm is focused on initiating Phase III program. The firm is exploring the use of BLU-5937 in other patient populations experiencing cough hypersensitivity as well as other P2X3-related hypersensitization conditions.
BLUENERGIES LTD
275 Armand-Frappier Blvd
Laval QUEBEC H7V 4A7 CA
CEO: Roberto Bellini
Employees: 74
Phone: 14506804500.0
The current stock price of BLU.CA is 0.65 CAD. The price decreased by -2.99% in the last trading session.
The exchange symbol of BLUENERGIES LTD is BLU and it is listed on the Toronto Stock Exchange exchange.
BLU.CA stock is listed on the Toronto Stock Exchange exchange.
BLUENERGIES LTD (BLU.CA) has a market capitalization of 82.42M CAD. This makes BLU.CA a Micro Cap stock.
BLUENERGIES LTD (BLU.CA) currently has 74 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BLU.CA does not pay a dividend.
BLUENERGIES LTD (BLU.CA) will report earnings on 2022-02-24.
ChartMill assigns a technical rating of 4 / 10 to BLU.CA.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |